Intersect Ent Inc (XENT) Return on Investment ROI from the first quarter of 2022 to first quarter of 2021 and for the year 2022, average high and low, overall ranking from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket
 


Intersect Ent Inc   (NASDAQ: XENT)


Intersect Ent Inc's ROI from its first quarter of 2022 to the first quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Intersect Ent Inc's ROI in the first quarter of 2022?
Intersect Ent Inc recorded a cumulative net loss of $-56 million during 12 months ending in the first quarter of 2022, resulting in a negative return on investment (ROI) of -44.77%.

Within the Healthcare sector 649 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2021 from 1746 to 4700.

Definition and Formula of Return on Investment



Return On Investment (Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Investment Change TTM -24.43 % -4.55 % 21.23 % 26.53 % 39.88 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 81 90 177 155 167
Return On Investment (TTM) -44.77 % 1.15 % -11.07 % -18.7 % -32.65 %
XENT's Overall Ranking # 4700 # 1746 # 213 # 142 # 631
Seq. Investment Change TTM -14.58 % -13.69 % 3.62 % -1.08 % 7.9 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -56 2 -19 -31 -54




Return On Investment XENT's Ranking
Within: No.
Industry # 169
Sector # 650
Overall # 4700

Return On Investment Statistics
High Average Low
11.53 %
-20.5 %
-47.21 %
(Dec 31 2014)   (Jun 30 2020)







Financial Statements
Intersect Ent Inc's I. Quarter Investments $ 81 Millions XENT's Balance sheet
Intersect Ent Inc's I. Quarter Income $ -58 Millions Quarterly XENT's Income Statement
XENT's Income by Division See XENT's Income by Division


XENT Annual Return On Investment (Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
Total Investments in Millions 90 183 129 121 118
Y / Y Investment Growth -51.02 % 42 % 6.38 % 2.82 % 2.15 %
Net Income in Millions 2 0 -43 -23 -16
Y / Y Net Income Growth 306.25 % - - - -
Annual Return On Investment 1.88 % 0.23 % -33.34 % -18.91 % -13.88 %


Annual Roi Comment
In the fiscal year 2021 ROI improved to 1.88 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
XENT's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for XENT's Competitors
Subscribers only: Roi for Intersect Ent Inc's Suppliers
Subscribers only: Return On Investment for XENT's Customers

Other Ratios
XENT's Roa XENT's Inventory Turnover Ratio XENT's Growth Rates XENT's Dividend Statistics
XENT's Profitability Ratios XENT's Asset Turnover Ratio XENT's Dividend Growth
XENT's Roe XENT's Valuation Ratios XENT's Financial Strength Ratios XENT's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2022, within Healthcare Sector ROI


Date modified: 2026-09-08T15:10:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.